http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2003301659-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c902faf6ae746c51fc8010672fc22894
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-315
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-315
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
filingDate 2003-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a4e2c02bc167bd2c8577749a7af7f8d
publicationDate 2004-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AU-2003301659-A1
titleOfInvention Combination of a growth hormone receptor antagonist such as pegvisomant and a cox-2 inhibitor such as celecoxib for the treatment of headache in patients with acromegaly
priorityDate 2002-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID58991
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2690
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2662
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25235
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506282
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID280805
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID14600
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID798613
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100001424

Total number of triples: 25.